TG Therapeutics Inc (STU:NKB2)
€ 16.184 0.574 (3.68%) Market Cap: 2.54 Bil Enterprise Value: 2.45 Bil PE Ratio: 80.14 PB Ratio: 17.02 GF Score: 73/100

TG Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 18, 2020 / 01:30PM GMT
Release Date Price: €16.55 (+1.97%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the TG Therapeutics 2020 Annual Meeting of Stockholders. I would now like to hand the conference to your speaker today, Sean Power, please go ahead, sir.

Sean A. Power
TG Therapeutics, Inc. - CFO, Corporate Secretary & Treasurer

Good morning. I'm Sean Power, Chief Financial Officer of TG Therapeutics, and will be presiding over today's meeting. In light of public health concerns due to COVID-19, we are broadcasting our meeting via live webcast.

On behalf of our company, I want to welcome you to our 2020 Annual Meeting of Stockholders, which is now formally called to order. We are very pleased to have each of you in attendance at today's virtual meeting.

Let me begin by introducing the directors of the company in attendance by means of remote communications. With us today are Michael Weiss, Laurence Charney, William Kennedy, Yann Echelard, Ken Hoberman, Daniel Hume and Dr. Sagar Lonial. Also virtually present here today is Michael Monahan of CohnReznick, our independent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot